Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6.

Kersting S, Reinecke K, Hilgert C, Janot MS, Haarmann E, Albrecht M, Müller AM, Herdegen T, Mittelkötter U, Uhl W, Chromik AM.

J Inflamm Res. 2013;6:13-23. doi: 10.2147/JIR.S36415. Epub 2013 Feb 12.

2.

Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice.

Chromik AM, Müller AM, Körner J, Belyaev O, Holland-Letz T, Schmitz F, Herdegen T, Uhl W, Mittelkötter U.

J Invest Surg. 2007 Jan-Feb;20(1):23-33.

PMID:
17365404
3.

The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium.

Kersting S, Behrendt V, Kersting J, Reinecke K, Hilgert C, Stricker I, Herdegen T, Janot MS, Uhl W, Chromik AM.

J Inflamm Res. 2013 May 3;6:71-81. doi: 10.2147/JIR.S40092. Print 2013.

4.

Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.

Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T.

J Gastroenterol Hepatol. 2003 May;18(5):560-9.

PMID:
12702049
5.

R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.

Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD.

Gastroenterology. 2007 Apr;132(4):1331-43. Epub 2007 Feb 6.

PMID:
17408649
6.

The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis.

Sheng YH, Lourie R, Lindén SK, Jeffery PL, Roche D, Tran TV, Png CW, Waterhouse N, Sutton P, Florin TH, McGuckin MA.

Gut. 2011 Dec;60(12):1661-70. doi: 10.1136/gut.2011.239194. Epub 2011 Jun 2.

PMID:
21636645
7.

Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10.

Pils MC, Bleich A, Prinz I, Fasnacht N, Bollati-Fogolin M, Schippers A, Rozell B, Müller W.

Inflamm Bowel Dis. 2011 Oct;17(10):2038-46. doi: 10.1002/ibd.21587. Epub 2010 Dec 22.

PMID:
21182023
8.

Oral administration of taurolidine ameliorates chronic DSS colitis in mice.

Chromik AM, Müller AM, Albrecht M, Rottmann S, Otte JM, Herdegen T, Uhl W, Mittelkötter U.

J Invest Surg. 2007 Sep-Oct;20(5):273-82.

PMID:
17972215
9.
10.

Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, Fichtner-Feigl S.

Gut. 2011 Dec;60(12):1678-86. doi: 10.1136/gutjnl-2011-300612. Epub 2011 Sep 23.

PMID:
21948944
11.

TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium-induced colitis in mice.

Liu Y, Zhang Z, Wang L, Li J, Dong L, Yue W, Chen J, Sun X, Zhong L, Sun D.

J Gastroenterol Hepatol. 2010 Jan;25(1):209-14. doi: 10.1111/j.1440-1746.2009.06046.x. Epub 2009 Nov 19.

PMID:
19929926
12.

CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.

Obermeier F, Dunger N, Strauch UG, Hofmann C, Bleich A, Grunwald N, Hedrich HJ, Aschenbrenner E, Schlegelberger B, Rogler G, Schölmerich J, Falk W.

Gastroenterology. 2005 Sep;129(3):913-27.

PMID:
16143131
13.

Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.

Peng XD, Wu XH, Chen LJ, Wang ZL, Hu XH, Song LF, He CM, Luo YF, Chen ZZ, Jin K, Lin HG, Li XL, Wang YS, Wei YQ.

J Pharmacol Exp Ther. 2010 Jan;332(1):46-56. doi: 10.1124/jpet.109.153494. Epub 2009 Oct 14.

14.

Regulation of gut inflammation and th17 cell response by interleukin-21.

Fina D, Sarra M, Fantini MC, Rizzo A, Caruso R, Caprioli F, Stolfi C, Cardolini I, Dottori M, Boirivant M, Pallone F, Macdonald TT, Monteleone G.

Gastroenterology. 2008 Apr;134(4):1038-48. doi: 10.1053/j.gastro.2008.01.041. Epub 2008 Jan 17.

PMID:
18395085
15.

Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.

Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Yanagisawa R, Inoue K, Takano H, Satoh M, Yoshida N, Okanoue T, Yoshikawa T.

Int J Mol Med. 2004 Aug;14(2):191-6.

PMID:
15254764
16.

MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.

Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R, Totsuka T, Takeda K, Akira S, Watanabe M.

J Gastroenterol. 2005 Jan;40(1):16-23.

PMID:
15692785
17.

Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.

Melgar S, Karlsson A, Michaëlsson E.

Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1328-38. Epub 2005 Jan 6.

18.

Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.

Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T.

Int J Mol Med. 2006 Jun;17(6):997-1004.

PMID:
16685407
19.

Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice.

Chung YW, Choi JH, Oh TY, Eun CS, Han DS.

Clin Exp Immunol. 2008 Jan;151(1):182-9. Epub 2007 Nov 15.

20.

Early-stage blocking of Notch signaling inhibits the depletion of goblet cells in dextran sodium sulfate-induced colitis in mice.

Shinoda M, Shin-Ya M, Naito Y, Kishida T, Ito R, Suzuki N, Yasuda H, Sakagami J, Imanishi J, Kataoka K, Mazda O, Yoshikawa T.

J Gastroenterol. 2010 Jun;45(6):608-17. doi: 10.1007/s00535-010-0210-z. Epub 2010 Feb 19.

PMID:
20169455

Supplemental Content

Support Center